OCUGEN OCGN 深 沪
等待开盘 06-29 09:30:00 美东时间
1.50
+0.130
+9.49%
华盛通- 最 高1.52
- 今 开1.36
- 成交量 5704.69万股
- 最 低 1.36
- 昨 收 1.37
- 总市值 5.08亿
- 52周最高 2.725
- 市盈率 静 --
- 换手率 16.85%
- 52周最低 0.9085
- 委 比 -79.80%
- 总股本 3.39亿
- 历史最高 18.77
- 量 比 5.38
- 振 幅 11.68%
- 历史最低 0.17
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Rockwell Medical announces 1-for-10 reverse stock split
Rockwell Medical (RMTI) board approved a 1-for-10 reverse stock split, effective July 1, 2026, as the company seeks to regain compliance with Nasdaq. The reverse split, previously authorized by shareh...
34分钟前
Definium Therapeutics launches $500M public offering
Definium Therapeutics (DFTX) announced plans for an underwritten public offering of $500M of common shares and, for certain investors, pre-funded warrants. Definium also intends to grant underwriters ...
06-23 04:08
Nasdaq, Take-Two, Fastly, Ocugen, Sony Insider Shock
Insiders have been trading these 5 stocks: (($NDAQ)), (($TTWO)), (($FSLY)), (($...
06-20 21:01
Ocugen Stockholders Approve Proposals and Confirm Leadership
An update from Ocugen ( ($OCGN) ) is now available. On June 11, 2026, Ocugen he...
06-12 06:56
CytomX gains as licensing deal with Regeneron expands
CytomX Therapeutics (CTMX) traded higher in the morning hours on Wednesday after the cancer drug developer announced an expanded collaboration and licensing agreement with Regeneron Pharmaceuticals (R...
06-03 21:52
美股大行评级 | 潜在涨幅99.91%！Tigress Financial上调英伟达目标价至425美元，维持"强力买入"评级
今日重点评级关注：Tigress Financial：维持英伟达"强力买入"评级，目标价从360美元升至425美元；康托·菲茨杰拉德：维持DeFi Development"超配"评级，目标价从6美元升至7美元
05-28 19:00
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11
Canaccord Genuity analyst Whitney Ijem maintains Ocugen (NASDAQ:OCGN) with a Buy and lowers the price target from $12 to $11.
05-27 20:51
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
Ocugen ( ($OCGN) ) just unveiled an announcement. Ocugen, Inc., based in Malver...
05-05 23:58
Ocugen stock dips as Q1 losses widen
Ocugen (OCGN) shares fell over 19% on Tuesday after the biotech’s net losses widened in Q1. Net loss for the quarter was $19.17M, compared to a $15.35M loss in the same period last year. The increased...
05-05 23:43
Full Transcript: Ocugen Q1 2026 Earnings Call
Ocugen (NASDAQ:OCGN) reported first-quarter financial results on Tuesday. The t...
05-05 23:11
